Robert Jaffe | Investor Relations |
Tim Crew | Chief Executive Officer |
John Kozlowski | Chief Financial Officer |
Maureen Cavanaugh | Chief Commercial Operations Officer |
Steve Lehrer | Leads, Insulin Biosimilar Initiatives |
Michael Parolari | Raymond James |
Matt Hewitt | Craig-Hallum |
Welcome to the Lannett Company Fiscal 2021 Fourth Quarter and Full Year Financial Results Conference Call. My name is Adrianne, and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please note this conference call is being recorded.